| 2000D-1350 - Draft Guidance for Industry on Labeling for Combined Oral Contraceptives; Availability | |||||||||||||||||||||||
| FDA Comment Number : | EC3 | ||||||||||||||||||||||
| Submitter : | Dr. Daniel Grossman | Date & Time: | 05/03/2004 06:05:07 | ||||||||||||||||||||
| Organization : | Population Council | ||||||||||||||||||||||
| Other Organization | |||||||||||||||||||||||
| Category : | |||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| I attempted to upload this comment earlier and received an error message, and this is a duplicate submission.
These comments are submitted on behalf of the Reproductive Health Program of the Population Council. Daniel Grossman, M.D., F.A.C.O.G., Population Council, One Dag Hammarskjold Plaza, New York, NY 10017 | |||||||||||||||||||||||